Literature DB >> 28190513

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28190513     DOI： 10.1016/j.ajo.2017.01.020

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  3 in total

1.  Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-25       Impact factor: 3.117

2.  Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-02       Impact factor: 3.117

3.  Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-04       Impact factor: 3.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.